|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1400 AUD | -6.67% |
|
+7.69% | -6.67% |
Company Valuation: Amplia Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 16.49 | 27.16 | 120.6 | 71.86 | - | - |
| Change | - | - | 343.99% | -40.4% | - | - |
| Enterprise Value (EV) 1 | 16.49 | 27.16 | 92.72 | 53.96 | 48.46 | 54.46 |
| Change | - | - | 241.42% | -41.8% | -10.19% | 12.38% |
| P/E | -2.64x | -3.27x | -14.3x | -6.09x | -20x | -12.7x |
| PBR | - | - | - | - | - | - |
| PEG | - | - | 0.6x | -0.2x | 0.3x | -0.2x |
| Capitalization / Revenue | - | - | - | - | 7.56x | 7.56x |
| EV / Revenue | - | - | - | - | 5.1x | 5.73x |
| EV / EBITDA | - | - | -11.2x | -4.69x | -12.1x | -9.08x |
| EV / EBIT | - | - | -11.1x | -4.65x | -11.8x | -8.93x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0214 | -0.0164 | -0.023 | -0.007 | -0.011 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 9.5 | 9.5 |
| EBITDA 1 | - | - | -8.297 | -11.5 | -4 | -6 |
| EBIT 1 | - | - | -8.389 | -11.6 | -4.1 | -6.1 |
| Net income 1 | -6.242 | -6.572 | -7.707 | -11.6 | -4.1 | -6.1 |
| Net Debt 1 | - | - | -27.85 | -17.9 | -23.4 | -17.4 |
| Reference price 2 | 0.0850 | 0.0700 | 0.2350 | 0.1400 | 0.1400 | 0.1400 |
| Nbr of stocks (in thousands) | 194,006 | 387,953 | 513,072 | 513,312 | - | - |
| Announcement Date | 30/05/23 | 30/05/25 | 29/05/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.52x | - | -5.14x | - | 54.38M | |
| 20.44x | 7.13x | 14.71x | 1.42% | 68.12B | |
| 31.44x | 8.03x | 24.45x | 0.05% | 55.18B | |
| -81.56x | 15.59x | -67.39x | -.--% | 28.63B | |
| 30.46x | 5.97x | 15.8x | -.--% | 23.99B | |
| -14.71x | 5.23x | -6.82x | -.--% | 23.53B | |
| 25.54x | 4.8x | 16.1x | -.--% | 18.45B | |
| -1250.29x | 38.99x | -15519.34x | -.--% | 16.44B | |
| 47.61x | 19.33x | 49.78x | 0.08% | 15.83B | |
| 16.76x | 4.95x | 11.57x | -.--% | 13.4B | |
| Average | -118.08x | 12.23x | -1,546.63x | 0.17% | 26.36B | |
| Weighted average by Cap. | -68.00x | 10.41x | -960.53x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATX Stock
- Valuation Amplia Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
